188 related articles for article (PubMed ID: 32648133)
1. Surgical outcome and graded prognostic assessment of patients with brain metastasis from adult sarcoma: multi-institutional retrospective study in Japan.
Deguchi S; Nakasu Y; Sakaida T; Akimoto J; Tanahashi K; Natsume A; Takahashi M; Okuda T; Asakura H; Mitsuya K; Hayashi N; Narita Y
Int J Clin Oncol; 2020 Nov; 25(11):1995-2005. PubMed ID: 32648133
[TBL] [Abstract][Full Text] [Related]
2. Brain Metastases and Place of Antiangiogenic Therapies in Alveolar Soft Part Sarcoma: A Retrospective Analysis of the French Sarcoma Group.
Malouf GG; Beinse G; Adam J; Mir O; Chamseddine AN; Terrier P; Honore C; Spano JP; Italiano A; Kurtz JE; Coindre JM; Blay JY; Le Cesne A
Oncologist; 2019 Jul; 24(7):980-988. PubMed ID: 30626710
[TBL] [Abstract][Full Text] [Related]
3. Institutional, retrospective analysis of 777 patients with brain metastases: treatment outcomes and diagnosis-specific prognostic factors.
Antoni D; Clavier JB; Pop M; Schumacher C; Lefebvre F; Noël G
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):630-7. PubMed ID: 23582409
[TBL] [Abstract][Full Text] [Related]
4. A nationwide multi-institutional retrospective study to identify prognostic factors and develop a graded prognostic assessment system for patients with brain metastases from uterine corpus and cervical cancer.
Hayashi N; Takahashi H; Hasegawa Y; Higuchi F; Takahashi M; Makino K; Takagaki M; Akimoto J; Okuda T; Okita Y; Mitsuya K; Hirashima Y; Narita Y; Nakasu Y;
BMC Cancer; 2017 Jun; 17(1):397. PubMed ID: 28577359
[TBL] [Abstract][Full Text] [Related]
5. Improving the Prognostic Value of Disease-Specific Graded Prognostic Assessment Model for Renal Cell Carcinoma by Incorporation of Cumulative Intracranial Tumor Volume.
Ali MA; Hirshman BR; Wilson B; Schupper AJ; Joshi R; Proudfoot JA; Goetsch SJ; Alksne JF; Ott K; Aiyama H; Nagano O; Carter BS; Chiang V; Serizawa T; Yamamoto M; Chen CC
World Neurosurg; 2017 Dec; 108():151-156. PubMed ID: 28754641
[TBL] [Abstract][Full Text] [Related]
6. External validation of Modified Breast Graded Prognostic Assessment for breast cancer patients with brain metastases: A multicentric European experience.
Griguolo G; Jacot W; Kantelhardt E; Dieci MV; Bourgier C; Thomssen C; Bailleux C; Miglietta F; Braccini AL; Conte P; Ferrero JM; Guarneri V; Darlix A
Breast; 2018 Feb; 37():36-41. PubMed ID: 29073498
[TBL] [Abstract][Full Text] [Related]
7. Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastases.
Sperduto PW; Kased N; Roberge D; Xu Z; Shanley R; Luo X; Sneed PK; Chao ST; Weil RJ; Suh J; Bhatt A; Jensen AW; Brown PD; Shih HA; Kirkpatrick J; Gaspar LE; Fiveash JB; Chiang V; Knisely JP; Sperduto CM; Lin N; Mehta M
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2111-7. PubMed ID: 21497451
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer patients with brain metastases or leptomeningeal disease: 10-year results of a national cohort with validation of prognostic indexes.
Znidaric T; Gugic J; Marinko T; Gojkovic Horvat A; Paulin Kosir MS; Golo D; Ivanetic Pantar M; Ratosa I
Breast J; 2019 Nov; 25(6):1117-1125. PubMed ID: 31286623
[TBL] [Abstract][Full Text] [Related]
9. Validation of Recursive Partitioning Analysis and Diagnosis-Specific Graded Prognostic Assessment in patients treated initially with radiosurgery alone.
Likhacheva A; Pinnix CC; Parikh N; Allen PK; Guha-Thakurta N; McAleer M; Sulman EP; Mahajan A; Shiu A; Luo D; Chiu M; Brown PD; Prabhu SS; Chang EL
J Neurosurg; 2012 Dec; 117 Suppl(0):38-44. PubMed ID: 23205787
[TBL] [Abstract][Full Text] [Related]
10. Validation of Modified Breast Graded Prognostic Assessment for breast cancer patients with brain metastases: extra-cranial disease progression is an independent risk factor.
Zhuang Q; Wong RX; Lian WX; Li YQ; Wong FY
Ann Palliat Med; 2019 Sep; 8(4):390-400. PubMed ID: 30943738
[TBL] [Abstract][Full Text] [Related]
11. Sarcoma metastatic to the brain: a series of 35 cases and considerations from 27 years of experience.
Salvati M; D'Elia A; Frati A; Santoro A
J Neurooncol; 2010 Jul; 98(3):373-7. PubMed ID: 20039192
[TBL] [Abstract][Full Text] [Related]
12. Recursive partitioning analysis (RPA) classification predicts survival in patients with brain metastases from sarcoma.
Grossman R; Ram Z
World Neurosurg; 2014 Dec; 82(6):1291-4. PubMed ID: 25102368
[TBL] [Abstract][Full Text] [Related]
13. Systemic treatment after whole-brain radiotherapy may improve survival in RPA class II/III breast cancer patients with brain metastasis.
Zhang Q; Chen J; Yu X; Ma J; Cai G; Yang Z; Cao L; Chen X; Guo X; Chen J
J Neurooncol; 2013 Sep; 114(2):181-9. PubMed ID: 23743596
[TBL] [Abstract][Full Text] [Related]
14. Development of a disease-specific graded prognostic assessment index for the management of sarcoma patients with brain metastases (Sarcoma-GPA).
Patrikidou A; Chaigneau L; Isambert N; Kitikidou K; Shanley R; Ray-Coquard I; Valentin T; Malivoir B; Laigre M; Bay JO; Moureau-Zabotto L; Bompas E; Piperno-Neumann S; Penel N; Alcindor T; Guillemet C; Duffaud F; Hügli A; Le Pechoux C; Dhermain F; Blay JY; Sperduto PW; Le Cesne A
BMC Cancer; 2020 Feb; 20(1):117. PubMed ID: 32050939
[TBL] [Abstract][Full Text] [Related]
15. Validation of the new Graded Prognostic Assessment scale for brain metastases: a multicenter prospective study.
Villà S; Weber DC; Moretones C; Mañes A; Combescure C; Jové J; Puyalto P; Cuadras P; Bruna J; Verger E; Balañà C; Graus F
Radiat Oncol; 2011 Mar; 6():23. PubMed ID: 21366924
[TBL] [Abstract][Full Text] [Related]
16. Predictors of quality of life and survival following Gamma Knife surgery for lung cancer brain metastases: a prospective study.
Bragstad S; Flatebø M; Natvig GK; Eide GE; Skeie GO; Behbahani M; Pedersen PH; Enger PØ; Skeie BS
J Neurosurg; 2018 Jul; 129(1):71-83. PubMed ID: 28820304
[TBL] [Abstract][Full Text] [Related]
17. A retrospective analysis of the prognosis of Japanese patients with sarcoma brain metastasis.
Toda Y; Kobayashi E; Kubota D; Miyakita Y; Narita Y; Kawai A
Cancer Med; 2023 Apr; 12(8):9471-9481. PubMed ID: 36811144
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors and grading systems for overall survival in patients treated with radiosurgery for brain metastases: variation by primary site.
Golden DW; Lamborn KR; McDermott MW; Kunwar S; Wara WM; Nakamura JL; Sneed PK
J Neurosurg; 2008 Dec; 109 Suppl():77-86. PubMed ID: 19123892
[TBL] [Abstract][Full Text] [Related]
19. Combined primary tumor and extracranial metastasis status as constituent factor of prognostic indices for predicting the overall survival in patients with brain metastases.
Park YH; Kim TH; Jung SY; Kim YE; Bae JM; Kim YJ; Choi JH; Lee NK; Moon SH; Kim SS; Shin KH; Kim JY; Kim DY; Cho KH
J Korean Med Sci; 2013 Feb; 28(2):205-12. PubMed ID: 23400308
[TBL] [Abstract][Full Text] [Related]
20. Analysis of Survival of Patients with Brain Metastases According to Prognostic Indexes and Treatment Strategies.
Saginc H; Baltalarli PB; Sagtas E; Coskun ME
Turk Neurosurg; 2020; 30(6):822-831. PubMed ID: 32091122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
